NPR
Trump administration will allow pharmacies to make popular peptides
Wednesday, October 28, 2026
The Department of Health and Human Services announced pharmacies will be permitted to compound six peptides without Food and Drug Administration approval. The peptides include semaglutide, tirzepatide, and four others used for weight loss and diabetes treatment. HHS did not specify whether the authorization applies only to small compounding pharmacies or all licensed pharmacies.
Original reporting: